摘要
TSH抑制治疗是分化型甲状腺癌的传统治疗手段之一，能降低肿瘤进展高危患者的复发率和死亡率，但它有潜在的心血管系统和骨骼系统的不良反应，因此，TSH抑制治疗应同时考虑可能带来的益处和潜在的不良反应风险，进行个体化治疗。
TSH suppression therapy plays an important role in differentiated thyroid carcinoma. It can lower mortality and recurrence rate in high risk patients. Meanwhile, it also has potential side effects on cardiovascular and skeletal systems. Thus, TSH suppressive therapy should be individualized in regard to its possible benefit and potential adverse effects.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2011年第6期533-536,共4页
Chinese Journal of Endocrinology and Metabolism
关键词
分化型甲状腺癌
促甲状腺素
抑制治疗
不良反应
Differentiated thyroid carcinoma
Thyrotropin
Suppressive therapy
Adverse effects
